Zobrazeno 1 - 10
of 66
pro vyhledávání: '"H, Sand Hansen"'
Autor:
Poul Bretlau, Henrik Albeck, N. Højgaard Nielsen, Hans H. Ockelmann, H. Sand Hansen, J. Bentzen
Publikováno v:
Cancer. 72:196-200
Background. Nasopharyngeal carcinoma (NPC) and anaplastic salivary gland carcinoma (SGC), both associated with Epstein-Barr virus (EBV), are common among Inuit from Greenland, Canada, and Alaska. Because immigrant studies have shown that factors acti
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 11(7)
Background: Results with docetaxel as single drug in squamouscell head and neck cancer have been encouraging. The purpose of the present phase II study is to evaluate the antitumour efficacy and toxicity of the combination of docetaxel and cisplatin
Autor:
L, Christensen, M, Blichert-Toft, M, Brandt, M, Lange, S B, Sneppen, J, Ravnsbaek, C L, Mollerup, L, Strange, F, Jensen, J, Kirkegaard, H, Sand Hansen, S S, Sørensen, U, Feldt-Rasmussen
Publikováno v:
Clinical endocrinology. 53(2)
To evaluate the value of immunostaining using the monoclonal antibody (MoAB47) against thyroperoxidase (TPO) in distinguishing between benign and malignant tumour cells in fine needle aspiration cytology (FNAC) samples obtained from a solitary cold n
Autor:
J.M. Nuutinen, Timo Kurki, Paula Lindholm, S. Holm, Maria Lapela, I. Bjornskov, Poul Bretlau, H. Sand Hansen, A. Eigtved, Lars Friberg, Sirkku Jyrkkiö, Olof Solin, Heikki Minn, E. Sutinen, Mikael Jensen, Reidar Grénman
Publikováno v:
European journal of cancer (Oxford, England : 1990). 36(7)
We evaluated positron emission tomography (PET) with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) in the detection of recurrent head and neck cancer, and compared visual and quantitative interpretation of PET images for their accuracy in the identif
Autor:
B. Melgaard, H. Sand Hansen, Z. Kamieniecka, O.B. Paulson, A.Gersel Pedersen, Xiaofu Tang, W. Trojaborg
Publikováno v:
Acta Neurologica Scandinavica. 65:107-108
Autor:
A.K. Berthelsen, Karsten Jørgensen, Jens Overgaard, H. Sand Hansen, B. Rasmusson, Birgit Lindeløv, Marie Overgaard
Publikováno v:
Overgaard, J, Sand Hansen, H, Lindeløv, B, Overgaard, M, Jørgensen, K, Rasmusson, B & Berthelsen, A 1991, ' Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85 ', Radiotherapy & Oncology, vol. 20, no. Suppl 1, pp. 143-9 .
Between January 1986 and September 1990, 442 patients with pharynx and supraglottic larynx carcinoma were randomized to receive the hypoxic cell radiosensitizer nimorazole (NIM) or placebo in association with a course of conventional primary radiothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94b91d8208f5f4cc2e0cf00b943e94f5
https://pure.au.dk/portal/da/publications/nimorazole-as-a-hypoxic-radiosensitizer-in-the-treatment-of-supraglottic-larynx-and-pharynx-carcinoma-first-report-from-the-danish-head-and-neck-cancer-study-dahanca-protocol-585(796e8326-dee8-4569-bf62-3662ddbca721).html
https://pure.au.dk/portal/da/publications/nimorazole-as-a-hypoxic-radiosensitizer-in-the-treatment-of-supraglottic-larynx-and-pharynx-carcinoma-first-report-from-the-danish-head-and-neck-cancer-study-dahanca-protocol-585(796e8326-dee8-4569-bf62-3662ddbca721).html
Publikováno v:
Clinical oncology (Royal College of Radiologists (Great Britain)). 2(2)
During the period 1978–82, 145 patients with Stage I glottic carcinoma had primary radiotherapy at the Finsen Institute in Copenhagen. Of these, 35 patients developed recurrence, corresponding to a local control rate of 76%. Following salvage surge
Autor:
J. Johansen, E. Andersen, Lisbeth Juhler Andersen, Camilla Molich Hoff, H. Sand Hansen, Marie Overgaard, Cai Grau, Lena Specht, Jens Overgaard, Jan F. Evensen
Publikováno v:
European Journal of Cancer Supplements. 5:7
Autor:
Marie Overgaard, Olfred Hansen, Jan F. Evensen, Lena Specht, Lennart Lynge Andersen, Lars Bastholt, Cai Grau, Jens Overgaard, Elo Andersen, H. Sand Hansen
Publikováno v:
European Journal of Cancer Supplements. 1:S318